Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Straight Talk About Nutritional Supplements
Herb Weisbaum, Consumers’ Checkbook
One A Day Multivitamin Gummies
Don’t confuse this product name for the serving size.
NutriDrip
Did Joe Rogan actually endorse this company’s IV drip?
TINA.org Supports FTC’s Ruling against Intuit’s Deceptive Advertising
Intuit should not advertise TurboTax Free Edition without making clear that most people cannot use it.
AmmoniaSport
FDA sends warning letter to smelling salts seller.